Detailed explanation of the standard dosage and daily dosage of Midostaurin

Midostaurin is an oral multi-target tyrosine kinase inhibitor mainly used to treat FLT3 mutated acute myeloid leukemia (AML) and certain systemic mastocytosis. It blocks tumor cell proliferation signaling pathways by inhibiting the activity of FLT3 and other related tyrosine kinases, thereby slowing down disease progression. Midostaurin is often used as part of a combination chemotherapy regimen to improve efficacy and prolong progression-free survival.

The clinically recommended standard dose is50 mg taken orally twice daily. For AML patients, midostaurin is usually used during chemotherapy and during the maintenance phase after chemotherapy. Each dose of 50 mg can achieve effective blood concentration while controlling drug side effects, so that hematological indicators and liver and kidney functions can fluctuate within a controllable range.

Midostaurin should be taken with or with food to increase drug absorption and reduce the risk of gastrointestinal upset. The interval between taking the medicine twice a day should be about 12 hours as much as possible to ensure stable blood drug concentration and avoid a decrease in efficacy or an increase in side effects caused by too high or too low blood drug concentration. Patients should regularly monitor blood routine, liver and kidney function and electrocardiogram during the medication period, and detect and deal with abnormal reactions in a timely manner.

In some patients, poor tolerance or significant side effects may occur, such as nausea, vomiting, diarrhea or hematological toxicity. At this time, the doctor can reduce the dose by half or temporarily stop the medication according to the patient's specific conditions, and then resume the standard dose after the symptoms are relieved. By individually adjusting the daily dosage and frequency of taking, the efficacy and safety of the drug can be taken into consideration to achieve the best therapeutic effect for patients with AML or other indications.

Reference materials:https://www.drugs.com/